Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)
HKD 1.66
(3.75%)
HKD 1.66
(3.75%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -404.81 Million CNY | 16.77% |
| 2022 | -486.38 Million CNY | 42.05% |
| 2021 | -839.26 Million CNY | -56.48% |
| 2020 | -536.32 Million CNY | -2377.97% |
| 2019 | -21.64 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -272.9 Million CNY | 32.59% |
| 2024 Q2 | -272.9 Million CNY | 0.36% |
| 2023 Q2 | -403.42 Million CNY | -5.66% |
| 2023 FY | -404.81 Million CNY | 16.77% |
| 2023 Q1 | -381.83 Million CNY | 21.5% |
| 2023 Q3 | -369.25 Million CNY | 8.47% |
| 2023 Q4 | -404.81 Million CNY | -9.63% |
| 2022 Q2 | -583.28 Million HKD | 0.0% |
| 2022 FY | -486.38 Million CNY | 42.05% |
| 2022 Q4 | -486.38 Million CNY | -10.33% |
| 2022 Q3 | -440.82 Million CNY | 24.42% |
| 2021 Q4 | -839.26 Million HKD | 0.0% |
| 2021 FY | -839.26 Million CNY | -56.48% |
| 2020 FY | -536.32 Million CNY | -2377.97% |
| 2019 FY | -21.64 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | -76.36 Million HKD | -430.075% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 107.686% |